Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1933 1
1946 2
1947 7
1948 2
1949 3
1950 3
1951 6
1952 7
1953 4
1954 4
1955 3
1956 1
1957 6
1958 4
1959 9
1960 1
1961 1
1962 8
1963 8
1964 10
1965 6
1966 6
1967 3
1968 9
1969 1
1970 5
1971 4
1972 6
1973 2
1974 6
1975 7
1976 5
1977 9
1978 6
1979 9
1980 3
1981 3
1982 1
1983 4
1984 6
1985 7
1986 4
1987 4
1988 8
1989 11
1990 5
1991 11
1992 10
1993 17
1994 7
1995 11
1996 9
1997 8
1998 12
1999 14
2000 20
2001 27
2002 24
2003 41
2004 46
2005 35
2006 76
2007 50
2008 47
2009 59
2010 71
2011 70
2012 90
2013 104
2014 100
2015 106
2016 101
2017 118
2018 115
2019 133
2020 144
2021 167
2022 115
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,979 results
Results by year
Filters applied: . Clear all
Page 1
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
Shaw AT, Riely GJ, Bang YJ, Kim DW, Camidge DR, Solomon BJ, Varella-Garcia M, Iafrate AJ, Shapiro GI, Usari T, Wang SC, Wilner KD, Clark JW, Ou SI. Shaw AT, et al. Among authors: wang sc. Ann Oncol. 2019 Jul 1;30(7):1121-1126. doi: 10.1093/annonc/mdz131. Ann Oncol. 2019. PMID: 30980071 Free PMC article. Clinical Trial.
Crizotinib in Patients With MET-Amplified NSCLC.
Camidge DR, Otterson GA, Clark JW, Ignatius Ou SH, Weiss J, Ades S, Shapiro GI, Socinski MA, Murphy DA, Conte U, Tang Y, Wang SC, Wilner KD, Villaruz LC. Camidge DR, et al. Among authors: wang sc. J Thorac Oncol. 2021 Jun;16(6):1017-1029. doi: 10.1016/j.jtho.2021.02.010. Epub 2021 Mar 4. J Thorac Oncol. 2021. PMID: 33676017 Free article.
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.
Chan LC, Li CW, Xia W, Hsu JM, Lee HH, Cha JH, Wang HL, Yang WH, Yen EY, Chang WC, Zha Z, Lim SO, Lai YJ, Liu C, Liu J, Dong Q, Yang Y, Sun L, Wei Y, Nie L, Hsu JL, Li H, Ye Q, Hassan MM, Amin HM, Kaseb AO, Lin X, Wang SC, Hung MC. Chan LC, et al. Among authors: wang sc. J Clin Invest. 2019 Jul 15;129(8):3324-3338. doi: 10.1172/JCI126022. eCollection 2019 Jul 15. J Clin Invest. 2019. PMID: 31305264 Free PMC article.
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration.
Drilon A, Clark JW, Weiss J, Ou SI, Camidge DR, Solomon BJ, Otterson GA, Villaruz LC, Riely GJ, Heist RS, Awad MM, Shapiro GI, Satouchi M, Hida T, Hayashi H, Murphy DA, Wang SC, Li S, Usari T, Wilner KD, Paik PK. Drilon A, et al. Among authors: wang sc. Nat Med. 2020 Jan;26(1):47-51. doi: 10.1038/s41591-019-0716-8. Epub 2020 Jan 13. Nat Med. 2020. PMID: 31932802 Free PMC article.
In Response.
Chang CY, Wu MY, Chien YJ, Su IM, Wang SC, Kao MC. Chang CY, et al. Among authors: wang sc. Anesth Analg. 2021 Aug 1;133(2):e27-e29. doi: 10.1213/ANE.0000000000005627. Anesth Analg. 2021. PMID: 34257211 No abstract available.
1,979 results